av/vivoryon-therapeutics-n-v--big.svg

COM:VIVORYON

Vivoryon Therapeutics AG

  • Stock

Last Close

2.00

22/11 14:58

Market Cap

49.61M

Beta: -

Volume Today

15.40K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
9
-
average payables
1.03K
-
1.18K
14.82%
1.33K
12.78%
1.76K
32.16%
1.12K
36.48%
558
50.11%
655.50
17.47%
725
10.60%
2.64K
263.52%
3.45K
30.96%
1.45M
41,860.64%
average receivables
2.50
-
1.98M
-
book value per share
-0.99
-
3.28
430.82%
2.35
28.52%
2.15
8.46%
1.09
49.30%
0.15
86.25%
3.40
2,168.79%
1.31
61.39%
0.83
36.93%
1.20
45.41%
capex per share
-0.00
-
-0.00
65.00%
-0.00
112.28%
-0.00
5.21%
-0.00
6.95%
-0.00
128.01%
-0.00
92.13%
-0.00
14.45%
-0.00
68.79%
-0.00
50.04%
capex to depreciation
-0.02
-
-0.02
33.62%
-0.11
403.57%
-0.07
32.65%
-0.07
8.49%
-0.70
953.42%
-0.53
23.22%
-0.44
17.92%
-0.12
72.35%
-0.07
43.63%
-3.08
4,404.84%
capex to operating cash flow
0.00
-
0.00
67.79%
0.00
161.52%
0.00
6.91%
0.00
9.39%
0.00
296.00%
0.00
76.99%
0.00
12.81%
0.00
61.10%
0.00
71.59%
0.02
4,627.61%
capex to revenue
-0.00
-
0.14
-
cash per share
1.19
-
4.30
261.38%
3.11
27.75%
2.87
7.55%
1.26
56.27%
0.46
63.33%
3.31
617.94%
1.32
60.20%
0.73
44.34%
1.21
64.52%
days of inventory on hand
days payables outstanding
1.01K
-
-2.95K
-
days sales outstanding
debt to assets
0.00
-
debt to equity
0.00
-
dividend yield
earnings yield
-0.17
-
-0.18
2.56%
-0.15
16.44%
-0.14
7.24%
-0.07
46.35%
-0.07
3.63%
-0.05
33.87%
-0.06
32.59%
-0.05
23.45%
-0.12
159.73%
enterprise value
52.04K
-
44.13K
15.19%
70.57K
59.91%
80.05K
13.42%
99.26K
24.01%
106.04K
6.83%
126.38K
19.18%
240.96K
90.66%
252.94K
4.97%
202.67K
19.87%
-18.52M
9,239.88%
enterprise value over ebitda
-5.57
-
-3.95
29.13%
-5.29
33.96%
-5.85
10.58%
-10.07
72.14%
-13.82
37.17%
-16.28
17.85%
-15.10
7.26%
-19.88
31.64%
-6.98
64.89%
0.64
109.10%
ev to operating cash flow
-6.10
-
-4.17
31.71%
-5.81
39.40%
-6.04
3.94%
-8.19
35.66%
-15.16
85.07%
-10.89
28.19%
-17.20
57.95%
-22.47
30.66%
-9.30
58.61%
0.86
109.25%
ev to sales
23.50
-
5.12
-
free cash flow per share
-2.01
-
-2.18
8.62%
-1.77
18.80%
-1.74
1.59%
-1.48
14.93%
-0.85
42.32%
-0.93
8.75%
-0.70
24.13%
-0.56
19.99%
-0.99
75.63%
free cash flow yield
-0.15
-
-0.16
8.62%
-0.13
18.80%
-0.13
1.59%
-0.11
14.93%
-0.06
42.32%
-0.07
8.75%
-0.05
24.13%
-0.04
19.99%
-0.10
125.73%
graham net net
-1.00
-
3.36
434.97%
2.39
28.76%
2.09
12.79%
1.03
50.56%
0.34
66.73%
3.05
789.30%
1.14
62.67%
0.33
70.63%
0.98
194.04%
graham number
7.16
-
13.19
84.20%
10.19
22.72%
9.39
7.85%
4.90
47.85%
1.78
63.60%
6.91
287.36%
4.94
28.45%
3.43
30.52%
5.89
71.42%
income quality
0.86
-
0.93
7.82%
0.90
2.85%
0.95
6.09%
1.51
58.55%
0.90
40.25%
1.48
64.15%
0.85
42.80%
0.89
4.81%
0.77
12.98%
0.76
1.81%
intangibles to total assets
0.02
-
0.00
75.91%
0.00
32.91%
0.00
67.60%
0.00
76.19%
0.00
69.18%
0.00
79.82%
0.02
5,343.40%
0.02
14.46%
0.02
27.57%
0
100%
interest coverage
-63.08
-
interest debt per share
inventory turnover
invested capital
0.00
-
market cap
56.92K
-
65.05K
14.29%
91.93K
41.32%
101.94K
10.89%
109.56K
7.47%
109.82K
0.24%
167.91K
52.89%
267.27K
59.18%
267.60K
0.13%
229.23K
14.34%
net current asset value
-3.38K
-
16.71K
593.91%
16.82K
0.60%
16.21K
3.60%
8.85K
45.38%
3.02K
65.91%
42.18K
1,297.65%
25.26K
40.11%
12.27K
51.45%
25.82K
110.52%
25.27M
97,742.92%
net debt to ebitda
0.52
-
1.87
258.32%
1.60
14.46%
1.60
0.06%
1.04
34.76%
0.49
52.80%
5.35
985.34%
1.65
69.19%
1.15
30.11%
0.91
20.64%
0.64
30.53%
net income per share
-2.29
-
-2.35
2.56%
-1.97
16.44%
-1.82
7.24%
-0.98
46.35%
-0.94
3.63%
-0.62
33.87%
-0.83
32.59%
-0.63
23.45%
-1.28
102.09%
operating cash flow per share
-2.00
-
-2.18
8.67%
-1.77
18.83%
-1.74
1.59%
-1.48
14.94%
-0.85
42.42%
-0.93
8.56%
-0.70
24.17%
-0.56
19.76%
-0.99
75.85%
payables turnover
0.36
-
-0.12
-
receivables turnover
research and ddevelopement to revenue
1.62
-
-4.87
-
return on tangible assets
-1.56
-
-0.53
65.64%
-0.62
15.85%
-0.62
0.73%
-0.74
19.43%
-1.91
157.01%
-0.17
91.09%
-0.57
231.51%
-0.53
6.74%
-0.91
72.80%
-0.92
0.84%
revenue per share
0.54
-
roe
2.31
-
-0.72
131.00%
-0.84
16.90%
-0.85
1.33%
-0.90
5.81%
-6.29
600.81%
-0.18
97.09%
-0.63
243.40%
-0.76
21.39%
-1.06
38.98%
-1.08
1.52%
roic
2.28
-
-0.71
130.88%
-0.83
17.68%
-0.84
1.34%
-1.25
48.74%
-6.26
400.14%
-0.18
97.08%
-0.61
234.34%
-0.80
31.07%
-1.11
38.20%
-1.11
0.07%
sales general and administrative to revenue
0.42
-
shareholders equity per share
-0.99
-
3.28
430.82%
2.35
28.52%
2.15
8.46%
1.09
49.30%
0.15
86.25%
3.40
2,168.79%
1.31
61.39%
0.83
36.93%
1.20
45.41%
stock based compensation to revenue
0.16
-
tangible asset value
-3.06K
-
16.82K
649.61%
16.90K
0.48%
16.28K
3.66%
8.91K
45.26%
3.08K
65.47%
42.65K
1,286.06%
25.66K
39.84%
16.02K
37.54%
26.01K
62.33%
26.28M
100,937.98%
tangible book value per share
-0.72
-
3.46
580.88%
2.46
28.90%
2.14
13.12%
1.09
49.06%
0.37
65.56%
3.40
806.59%
1.28
62.21%
0.80
37.62%
1.18
47.45%
working capital
-3.38K
-
16.71K
593.91%
16.82K
0.60%
17.06K
1.45%
10.03K
41.23%
3.02K
69.90%
44.45K
1,372.73%
27.47K
38.20%
15.18K
44.74%
27.43K
80.72%
26.63M
96,987.02%

All numbers in (except ratios and percentages)